Table 3 Primary and secondary outcomes of all participants (AR-ALL, n=84) after 20 training sessions (ITT analysis)

FMA-UE (max. 66)^†

36.70 ± 20.03

38.95 ± 20.16

2.25 ± 4.14

0.000003**

FMA-LE (max. 34)^†

19.19 ± 7.21

20.88 ± 7.36

1.69 ± 4.46

0.00082**

BBS (max. 56)^†

42.17 ± 11.13

43.52 ± 10.21

1.35 ± 4.14

0.004**

FAC (max. 6)^†

4.69 ± 1.05

4.82 ± 1.06

0.14 ± 0.67

0.084

BI (max. 20)^†

16.72 ± 2.54

17.60 ± 2.40

0.88 ± 1.13

0.0007**

SF-12v2 PCS (max. 100)^†

32.15 ± 10.48

35.00 ± 9.81

2.85 ± 7.47

0.0008*

SF-12v2 MCS (max. 100)^†

43.29 ± 17.55

46.04 ± 13.63

2.75 ± 11.40

0.030*